Xylo Technologies Ltd. American (XYLO) Financials

XYLO

FY2024 annual

Revenue $29.9M -67.4% YoY

Net Income -$12.0M +44.8% YoY

Free Cash Flow -$1.8M +70.8% YoY

Operating Cash Flow -$1.8M +70.8% YoY

Source SEC Filings (10-K/10-Q) Latest period FY2024, ended Dec 31, 2024 Reported Apr 30, 2025 Currency USD FYE December

Newest figures come from the 10-K for FY2024, filed Apr 30, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the XYLO SEC filings page.

Xylo Technologies Ltd. American (XYLO) reported $29.9M in revenue for fiscal year 2024, down 67.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI XYLO FY2024 2026-10-04

The business is shrinking while its cash drain eases, but losses remain large and reinvestment is minimal.

From FY2023 to FY2024, revenue fell to $29.9M from $91.7M, yet operating cash outflow improved to $1.8M from $6.2M; the smaller cash drain indicates reported losses are not translating dollar-for-dollar into cash consumption. FY2024 free cash flow of -$1.8M was close to operating cash flow while capital expenditures were only $12K, so the cash deficit reflects ongoing operations more than heavy reinvestment.

The balance sheet contracted sharply: total assets fell to $37.5M from $63.9M in FY2023, reducing the asset base supporting operations. Liabilities of $20.0M now exceed equity of $17.6M, leaving less balance-sheet cushion against further losses.

Net margin worsened to -40.2% from -23.7%, so the 2024 cash-flow improvement is not an earnings recovery; it occurred alongside a much smaller revenue base. The current ratio remained near 1.1x while operations still consumed cash, leaving only a narrow short-term liquidity buffer.

Financial Health Signals

Financial health score not available

Xylo Technologies Ltd. American does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/7

Xylo Technologies Ltd. American passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Xylo Technologies Ltd. American reported a net loss of $12.0M while operations used $1.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2024.

Cash & Balance Sheet

Cash & Debt

$8.8M

YoY-6.5%

QoQ+31.1%

Xylo Technologies Ltd. American held $8.8M in cash as of Q4 2024; long-term debt is not reported for that period.

Shares Outstanding

32M

YoY+15.3%

Xylo Technologies Ltd. American had 32M shares outstanding in Q4 2024. This represents an increase of 15.3% from the same quarter a year earlier.

Free Cash Flow

Not reported for Q4 2024.

Dividends Per Share

Not reported for Q4 2024.

Margins & Returns

None of these metrics is reported for Q4 2024.

Capital Allocation

None of these metrics is reported for Q4 2024.

XYLO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XYLO quarterly income statement

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Revenue	$29.9M-67.4%	$91.7M-0.1%	$91.9M+807.9%	$10.1M+1805.5%	$531K+94.5%	$273K-37.4%	$436K-6.6%	$467K-14.9%	$549K-12.0%	$624K
Interest Expense	$81K-1.2%	$82K0.0%	$82K-82.6%	$470K+129.3%	$205K+107.1%	$99K+5.3%	$94K+452.9%	$17K+41.7%	$12K-63.6%	$33K
Income Tax	-$257K-247.3%	-$74K-166.7%	$111K+5.7%	$105K+1066.7%	$9K+1000.0%	-$1K-105.0%	$20K+385.7%	-$7K-125.0%	$28K-58.8%	$68K
Net Income	-$12.0M+44.8%	-$21.7M-112.9%	-$10.2M-352.3%	$4.0M+159.1%	-$6.8M+51.7%	-$14.2M-114.9%	-$6.6M-159.3%	-$2.5M+71.7%	-$9.0M+5.5%	-$9.5M
Diluted Shares (Avg)	29,756+17.6%	25,292+3.7%	24,385+5.9%	23,036+245.3%	6,672	N/A	N/A	N/A	N/A	N/A

Metric	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q	Q4'2110-K	Q2'2110-Q

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

XYLO Balance Sheet

XYLO quarterly balance sheet

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Total Assets	$37.5M-41.2%	$63.9M-34.6%	$97.7M+63.5%	$59.7M+84.7%	$32.3M+142.5%	$13.3M+18.6%	$11.2M+55.9%	$7.2M+52.6%	$4.7M	N/A
Current Assets	$21.0M-33.7%	$31.7M-39.4%	$52.3M+65.1%	$31.7M+31.6%	$24.0M+190.4%	$8.3M-25.6%	$11.1M+63.4%	$6.8M+90.0%	$3.6M	N/A
Cash & Equivalents	$8.8M-6.5%	$9.4M-53.4%	$20.1M-16.5%	$24.0M+7.4%	$22.4M+217.8%	$7.0M-33.8%	$10.6M+275.7%	$2.8M-5.8%	$3.0M-70.9%	$10.3M
Inventory	N/A	$2.4M+33.2%	$1.8M+46.0%	$1.2M+404.9%	$243K-73.0%	$900K+1011.1%	$81K-55.0%	$180K-9.1%	$198K	N/A
Accounts Receivable	N/A	N/A	N/A	$999K	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$4.8M-37.7%	$7.7M-78.4%	$35.7M+3139.8%	$1.1M+122.6%	$495K+223.5%	$153K+920.0%	$15K-6.3%	$16K-38.5%	$26K	N/A
Total Liabilities	$20.0M-36.6%	$31.5M-26.8%	$43.0M+417.8%	$8.3M+35.1%	$6.1M+18.0%	$5.2M+64.7%	$3.2M+86.0%	$1.7M-5.5%	$1.8M	N/A
Current Liabilities	$18.4M-37.1%	$29.3M-22.2%	$37.6M+466.8%	$6.6M+88.9%	$3.5M+4.4%	$3.4M+13.6%	$3.0M+95.4%	$1.5M+13.6%	$1.3M	N/A
Non-Current Liabilities	$1.5M-29.9%	$2.2M-58.9%	$5.3M+221.8%	$1.7M-36.9%	$2.6M+42.9%	$1.8M+833.0%	$197K+7.7%	$183K-60.5%	$463K	N/A
Long-Term Debt	N/A	$468K	N/A	N/A	$47K+42.4%	$33K+266.7%	$9K	N/A	N/A	N/A
Total Equity	$17.6M-45.8%	$32.4M-40.7%	$54.7M+6.3%	$51.4M+96.4%	$26.2M+222.1%	$8.1M+0.6%	$8.1M+46.6%	$5.5M+88.3%	$2.9M-71.3%	$10.2M
Retained Earnings	-$107.6M-5.9%	-$101.6M-18.7%	-$85.6M-15.4%	-$74.2M+8.4%	-$81.0M-5.6%	-$76.7M-22.7%	-$62.5M-11.8%	-$55.9M-4.8%	-$53.3M	N/A

Metric	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q	Q4'2110-K	Q2'2110-Q
Total Assets	$37.5M-41.2%	$39.3M-54.1%	$63.9M-34.6%	$85.7M-9.2%	$97.7M+63.5%	$94.3M+48.3%	$59.7M+84.7%	$63.6M+255.4%
Current Assets	$21.0M-33.7%	$19.4M-58.2%	$31.7M-39.4%	$46.5M+1.3%	$52.3M+65.1%	$46.0M+37.4%	$31.7M+31.6%	$33.4M+177.4%
Cash & Equivalents	$8.8M-6.5%	$6.7M-46.0%	$9.4M-53.4%	$12.4M-44.2%	$20.1M-16.5%	$22.1M-25.3%	$24.0M+7.4%	$29.6M+191.4%
Inventory	N/A	N/A	$2.4M+33.2%	$2.5M+38.9%	$1.8M+46.0%	$1.8M+68.4%	$1.2M+404.9%	$1.1M-12.3%
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	$728K	$999K	N/A
Goodwill	$4.8M-37.7%	N/A	$7.7M-78.4%	N/A	$35.7M+3139.8%	$29.4M+252.8%	$1.1M+122.6%	$8.3M+6068.1%
Total Liabilities	$20.0M-36.6%	$23.4M-43.3%	$31.5M-26.8%	$41.2M+0.2%	$43.0M+417.8%	$41.1M+324.0%	$8.3M+35.1%	$9.7M+117.4%
Current Liabilities	$18.4M-37.1%	$20.5M-42.9%	$29.3M-22.2%	$35.9M+8.1%	$37.6M+466.8%	$33.2M+397.7%	$6.6M+88.9%	$6.7M+51.4%
Non-Current Liabilities	$1.5M-29.9%	$2.9M-45.8%	$2.2M-58.9%	$5.3M-32.8%	$5.3M+221.8%	$7.9M+162.0%	$1.7M-36.9%	$3.0M+5131.0%
Long-Term Debt	N/A	N/A	$468K	N/A	N/A	$536K	N/A	N/A
Total Equity	$17.6M-45.8%	$15.9M-64.2%	$32.4M-40.7%	$44.4M-16.4%	$54.7M+6.3%	$53.2M-1.3%	$51.4M+96.4%	$53.9M+301.2%
Retained Earnings	-$107.6M-5.9%	-$109.8M-17.1%	-$101.6M-18.7%	-$93.8M-20.6%	-$85.6M-15.4%	-$77.8M-8.2%	-$74.2M+8.4%	-$71.9M+9.2%

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.

XYLO Cash Flow Statement

XYLO quarterly cash flow statement

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Operating Cash Flow	-$1.8M+70.8%	-$6.2M-10.4%	-$5.7M-7.7%	-$5.3M+14.5%	-$6.1M-127.9%	-$2.7M+36.2%	-$4.2M+9.8%	-$4.7M+49.5%	-$9.3M-32.7%	-$7.0M
Capital Expenditures	$12K-76.5%	$51K-31.1%	$74K-47.5%	$141K-56.5%	$324K+422.6%	$62K+463.6%	$11K+22.2%	$9K-71.9%	$32K-61.9%	$84K
Free Cash Flow	-$1.8M+70.8%	-$6.3M-9.9%	-$5.7M-6.3%	-$5.4M+16.6%	-$6.5M-134.6%	-$2.8M+34.9%	-$4.2M+9.7%	-$4.7M+49.6%	-$9.3M-31.6%	-$7.1M
Investing Cash Flow	$2.4M+265.8%	-$1.4M+67.9%	-$4.5M+64.0%	-$12.4M-677.4%	-$1.6M+61.1%	-$4.1M-218.1%	$3.5M+199.4%	-$3.5M-9134.2%	-$38K+60.4%	-$96K
Financing Cash Flow	-$998K+68.3%	-$3.1M-158.2%	$5.4M-71.7%	$19.1M-16.5%	$22.9M+627.1%	$3.2M-63.4%	$8.6M+9.0%	$7.9M+316.4%	$1.9M-71.9%	$6.8M
Dividends Paid	N/A	$728K-54.0%	$1.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q	Q4'2110-K	Q2'2110-Q

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

XYLO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XYLO quarterly financial ratios

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Net Margin	-40.2%-16.5pp	-23.7%-12.6pp	-11.1%-51.1pp	40.0%	-1290.0%	-5193.4%	-1513.3%	-545.0%	-1640.6%	-1527.6%
Return on Equity	-68.3%-1.2pp	-67.0%-48.3pp	-18.7%-26.5pp	7.9%+34.0pp	-26.2%+148.2pp	-174.4%-92.7pp	-81.7%-35.5pp	-46.2%+261.5pp	-307.7%-214.1pp	-93.6%
Return on Assets	-32.0%+2.0pp	-34.0%-23.6pp	-10.4%-17.2pp	6.8%+27.9pp	-21.2%+85.1pp	-106.3%-47.6pp	-58.7%-23.4pp	-35.3%+155.4pp	-190.7%	N/A
Current Ratio	1.14+0.1x	1.08-0.3x	1.39-3.4x	4.77-2.1x	6.84+4.4x	2.46-1.3x	3.76-0.7x	4.49+1.8x	2.69	N/A
Debt-to-Equity	1.13+1.1x	0.01-0.8x	0.79+0.6x	0.16+0.2x	0.000.0x	0.000.0x	0.00-0.3x	0.31-0.3x	0.61	N/A
Asset Turnover	0.80-0.6x	1.44+0.5x	0.94+0.8x	0.17+0.2x	0.020.0x	0.020.0x	0.040.0x	0.06-0.1x	0.12	N/A
FCF Margin	-6.2%+0.7pp	-6.9%-0.6pp	-6.2%+47.0pp	-53.3%	-1217.9%	-1009.9%	-970.9%	-1004.3%	-1693.4%	-1132.2%

Metric	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q	Q4'2110-K	Q2'2110-Q
Current Ratio	1.14+0.1x	0.95-0.3x	1.08-0.3x	1.30-0.1x	1.39-3.4x	1.39-3.6x	4.77-2.1x	5.02+2.3x
Debt-to-Equity	1.13+1.1x	1.47+0.5x	0.01-0.8x	0.93+0.9x	0.79+0.6x	0.01-0.2x	0.16+0.2x	0.18+0.2x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Xylo Technologies Ltd. American XYLO	FY2024	$29.9M	-$12.0M	-40.2%	$6.6M	—
Autonomix Medical, Inc. AMIX	FY2026	$0	-$16.7M	N/A	$6.8M	—
Corvex, Inc. MOVE	FY2025	$433K	-$18.3M	N/A	$334.1M	—
ReShape Lifesciences, Inc. RSLS	FY2025	$320K	-$10.3M	N/A	$7.6M	—
Lifeward Ltd. LFWD	FY2025	$22.0M	-$19.9M	-90.3%	$18.0M	47/100
HeartSciences Inc. HSCS	FY2026	$4K	-$9.1M	N/A	$18.3M	—

Where Xylo Technologies Ltd. American Ranks

Frequently Asked Questions

What is Xylo Technologies Ltd. American's annual revenue?

Xylo Technologies Ltd. American (XYLO) reported $29.9M in total revenue for fiscal year 2024. This represents a -67.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Xylo Technologies Ltd. American's revenue growing?

Xylo Technologies Ltd. American (XYLO) revenue declined by 67.4% year-over-year, from $91.7M to $29.9M in fiscal year 2024.

Is Xylo Technologies Ltd. American profitable?

No, Xylo Technologies Ltd. American (XYLO) reported a net income of -$12.0M in fiscal year 2024, with a net profit margin of -40.2%.

What is Xylo Technologies Ltd. American's net profit margin?

Xylo Technologies Ltd. American (XYLO) had a net profit margin of -40.2% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Xylo Technologies Ltd. American's return on equity (ROE)?

Xylo Technologies Ltd. American (XYLO) has a return on equity of -68.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Xylo Technologies Ltd. American's free cash flow?

Xylo Technologies Ltd. American (XYLO) recorded an outflow of $1.8M in free cash flow during fiscal year 2024. This represents a 70.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Xylo Technologies Ltd. American's operating cash flow?

Xylo Technologies Ltd. American (XYLO) recorded an outflow of $1.8M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

What are Xylo Technologies Ltd. American's total assets?

Xylo Technologies Ltd. American (XYLO) had $37.5M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Xylo Technologies Ltd. American's capital expenditures?

Xylo Technologies Ltd. American (XYLO) invested $12K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does Xylo Technologies Ltd. American have outstanding?

Xylo Technologies Ltd. American (XYLO) had 32M shares outstanding as of fiscal year 2024.

What is Xylo Technologies Ltd. American's current ratio?

Xylo Technologies Ltd. American (XYLO) had a current ratio of 1.14 as of fiscal year 2024, which is considered adequate.

What is Xylo Technologies Ltd. American's debt-to-equity ratio?

Xylo Technologies Ltd. American (XYLO) had a debt-to-equity ratio of 1.13 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Xylo Technologies Ltd. American's return on assets (ROA)?

Xylo Technologies Ltd. American (XYLO) had a return on assets of -32.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Xylo Technologies Ltd. American's Piotroski F-Score?

Xylo Technologies Ltd. American (XYLO) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Xylo Technologies Ltd. American's earnings high quality?

Xylo Technologies Ltd. American (XYLO) reported a net loss of $12.0M while operations used $1.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.